Literature DB >> 2260099

Echocardiographic and radionuclide angiographic observations following scorpion envenomation by Leiurus quinquestriatus.

M Gueron1, G Margulis, S Sofer.   

Abstract

The echocardiographic and radionuclide angiographic abnormalities in children after scorpion envenomation with L. quinquestriatus, were evaluated. Five children were severely hypertensive, one of them in respiratory failure and another had pulmonary edema. The results revealed poor global contractility 12-15 hr after the sting in three patients. The radionuclide angiograms also revealed poor contractility with low ejection fraction. There was enzymatic evidence of myocardial damage. The changes observed in the echocardiograms and radionuclide angiograms were attributed to catecholamine induced myocardial ischemia. The abnormalities observed suggest that systolic dysfunction plays a role in the pathogenesis of heart failure in scorpion envenomation, in addition to a decrease of left ventricular compliance and increased impedance to left ventricular emptying. The beneficial effects of nifedipine in hypertension and other cardiovascular manifestations justify the routine use of afterload reduction in children with cardiovascular manifestations after scorpion envenomation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260099     DOI: 10.1016/0041-0101(90)90138-w

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  10 in total

1.  Indian red scorpion envenoming.

Authors:  H S Bawaskar; P H Bawaskar
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

Review 2.  Scorpion envenomation.

Authors:  S Sofer
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

3.  Echocardiography guided therapy for myocarditis after scorpion sting envenomation.

Authors:  Suresh V Sagarad; Sudha Biradar Kerure; Balaramsingh Thakur; S S Reddy; Balasubramanya K; R M Joshi
Journal:  J Clin Diagn Res       Date:  2013-12-15

4.  NT-proBNP in Myocarditis after a Scorpion Sting Envenomation.

Authors:  Suresh V Sagarad; Balaram Singh Thakur; S S Reddy; Balasubramanya K; R M Joshi; Sudha Biradar Kerure
Journal:  J Clin Diagn Res       Date:  2013-01-01

5.  Evidence of myocardial ischaemia in severe scorpion envenomation. Myocardial perfusion scintigraphy study.

Authors:  Mabrouk Bahloul; Chokri Ben Hamida; Khalil Chtourou; Hichem Ksibi; Hassen Dammak; Hatem Kallel; Adel Chaari; Hedi Chelly; Fadhel Guermazi; Noureddine Rekik; Mounir Bouaziz
Journal:  Intensive Care Med       Date:  2003-12-12       Impact factor: 17.440

6.  Elevated Cardiac Troponin (cTnI) Levels Correlate with the Clinical and Echocardiographic Evidences of Severe Myocarditis in Scorpion Sting Envenomation.

Authors:  Suresh V Sagarad; Balaram Singh Thakur; S S Reddy; K Balasubramanya; R M Joshi; Sudha Biradar Kerure
Journal:  J Clin Diagn Res       Date:  2012-10

7.  Assessment of left ventricular function in severe scorpion envenomation: combined hemodynamic and echo-Doppler study.

Authors:  F Abroug; M Ayari; S Nouira; H Gamra; R Boujdaria; S Elatrous; M Ben Farhat; S Bouchoucha
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

8.  Management of the cardiovascular manifestations of poisoning by the Indian red scorpion (Mesobuthus tamulus).

Authors:  H S Bawaskar; P H Bawaskar
Journal:  Br Heart J       Date:  1992-11

9.  Echocardiography versus cardiac biomarkers for myocardial dysfunction in children with scorpion envenomation: An observational study from tertiary care center in northern India.

Authors:  Rajniti Prasad; Anil Kumar; Dharmendra Jain; B K Das; Utpal Kant Singh; T B Singh
Journal:  Indian Heart J       Date:  2020-08-02

10.  Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms.

Authors:  Hadjer Saidi; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-04-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.